US2689854A - Acetopyrrothine and preparation thereof - Google Patents

Description

Sept. 21,

PERCENT TRANSMITTANCY 1954 F. w. TANNER, JR, ETAL 2,689,854

ACETOPYRROTHINE AND PREPARATION THEREOF Filed May 3, 1950 INFRARED ABSORBTION SPECTRUM 0F ACETOPYRROTHINE I350 I300 I260 I200 [I50 "00 I050 I000 950 300 850 800 750 700 650 FREQUENCY m CM-' INVENTORS:.

FRED W.TANNER, JR, .mcoa W.DAVISSON ALEXANDER C.FINLAY BMJASPER H. KANE,

am amwag THEIR ATTORNEY Patented Sept. 21, 1954 UNITED STATE S PATENT OFFICE Application May 3, 1950, Serial No. 159,856

5 Claims.

This invention is concerned with a new and useful antibiotic called acetopyrrothine (also known by the registered trade-make Thiolutin) and with the production of this valuable subber of newly isolated strains of the species of microorganism known as Streptomyces albus. The description of the cultural characteristics of one of these new strains of S. albus is given in stance. More particularly it relates to processes 5 tabular form below. (The colors where R is for its production by fermentation, methods for written are those of Ridgway Color Standards its recovery and concentrat1on from crude soluand Nomenclature) Readmgs are based on tions includlng the fermentation broths, purifica- SIX tubes or plates, except where otherwise noted.

Color Amount of Medium Growth Remarks ggg gggilg Soluble Pigment Glucose-Asparagine Plates... Moderate to White with traces Faint yellow Colony elevated; edge smooth; surface wrinkled; Good. of Pale Vinacesporulation very slight; reverse light brownish ous Fawn (R) yellow. Spores borne in straight or wavy where sporuchains that develop in clusters; spores 0.65 x ted. 0.9g, oval to short cylindrical. No spirals. (11111 dilution plates colonies very similar to each 0 er. Gelatin Moderate... Slight sporulation Yellow Reverse light brown. Moderate liquefaction;

Pale Brownish v diameter of zones 16, 18, 10, 13, 15, 11 mm. Vinaceous (R), rest of aerial mycelium white. Milk (Pasteurized milk from Good Very slight coagulation in 13 days. N o visible which most of cream was peptonization. pH unchanged. removed was steamed on three successive days). Ammo nitrogen (Van Slyke) 7 days Control 0.90 men/ml. S. allms 1.01 mg./ml.

13 days Control 0.52 mgJml. S. albus 0.57 mgJml.

Total N (Kjeldahl) 7 days ControL. 5.17 mgJml. S. albus.. 5.59 mg./ml.

.... 4.76 mgJml. 1.95 mg./ml. Glucose Agar ..do Sporulation good Brown l to moderate, Pale Quaker Drab (R). Nutrient Agar Moderate.... Mostly white but Faint Yellow Reverse light brown; colony circumferentially some Pallid fissured. Mouse Gray (R) sporulation. Potato Plug Good sporulation mod- Light yellowish-brown erate, near Pale to dark brown. Olive Bull (R). Calcium malate Poor White, flufiy aer- None ial mycelium; sporulation nearly lacking. Starch plates ..do Flat, white aerial do Reverse brown. Moderate hydrolysis: zones 14 mycelium; no mm. in diameter. spores. Synthetic Agar .-do White, dull waxy; None Reverse white.

110 aerial mycelium or spores. Cellnlnso Nrma Emerson's Agar Good Mostly fiat, white, Orange brown Reverse brown.

aerial mycelium, slight Pallid Mouse Gray (R) sporulation in center. Dextrose Nitrate broth N 0 reduction.

tion thereof, and the preparation of the antibiotic in pure, crystalline form. The invention also includes the antibiotic in dilute solutions, as crude concentrates and in its pure, crystalline form.

Our new antibiotic is formed during the cultivation under controlled conditions of a num- 60 Manual.

This new strain of S. albus has been shown to differ in a number of tests from the description of this species given by Waksman in Bergeys The following table summarizes these differences, as well as the corresponding cultural characteristics of two strains of S. aZbus obtained 3 from the American Type Culture Collection (ATCC 618 and A'ICC 3004). It will be noted that this new strain differs particularly with respect to pigment formation. A culture of the 4 In addition to the activity demonstrated by the above table, we have found that acetopyrrothine is quite active against a strain of A. aerogenes which has been made resistant to aureomycin and new organism has been deposited with the Fer- 5 chloramphenicol, and that it also is active against mentation Division of the Northern Regional a strain of A. aerogenes which has been made Research Laboratory at Peoria, Illinois, and has resistant to streptomycin and streptothricin. In been added to its permanent collection of microaddition to the above organisms, acetopyrrothine organisms as NRRL #2401. shows great activity against a number of differ- S. aZbus S. albus S. albus S. albus Medium Waksmans description A'ICO 618 (Kluyver) ATCC 3004 (Waksman) Our Isolate Glucose-asparagine No data Sporulation good Sporulation good Sporulation very slight.

agar. I

do Reverse brown Reverse light brown Reverselightbrownish yellow.

Spirals Spirals Few spirals No spirals. Spores 1p long, ellip- Spores 0.65 x 1.0-1.2 short Spores 0.65-1.0 x 1-1.3 short Spores 0.65 x 0.9 short cysoidal. cylindric. cylindric. lindric. Gelatin No data Poor growthnfl Moderate growth Moderate growth.

Liquefaction Slight liquefaction. Moderate liquefaction- Moderate liquefaction. No soluble pigmentnm No soluble pigment No soluble pigment Yellow soluble pigment. Glucose agar Aerial mycelium, gray White aerial mycelium White aerial mycelium Pale Quaker Drab (R) .Sporubecoming brownish. lation. Nutrient agar N 0 data No soluble pigment. No soluble pigment Pigmentfaint yellow. Potato plug Aerial mycelium, white Aerial mycelium, white"... Aerial mycelium, white Aerial near Pale 0 we u Calcium malate Growth, moderate Growth, moderate Growth, moderate Growth, poor. Starch plates No data Growth, poor... Growth, moderate. Growth, poor.

'No hydrolysis No hydrolysis Weak hydrolysis-.. Moderate hydrolysis. Synthetic agar No data Aerial mycehum, white Aerial mycelium, white No aerial mycelium. Cellulose No growth N0 growth" Slight growth No growth. Emcrsons agarmn No data No soluble pigment Light yellowsoluble pigment Orange brownsoluble pigment.

in two tubes, none in four. Nitrate broth Nitrites produced No reduction N 0 reduction No reduction.

In addition to the differences tabulated above, we have found that our new antibiotic, acetopyrrothine is not produced, when S. allms ATCC 618 and S. albus ATCC 3004 are grown under the same conditions that produce the antibiotic, when our new strains of S. oallms are used.

It is to be understood that for the production of acetopyrrothine we do not wish ;to limit ourselves to this particular organism :or to organisms which exactly conform to the above description, which is merely given for illustrative purposes. -We have shown that several other strains of .S. albus also produce aoetopyrrothine and we especially wish to include the use of organisms which are mutants produced from the above-described organism by such agents as X-radiation, ultraviolet radiation, nitrogen mustards, etc.

Acetopyrrothine has a considerable activity against a variety of microorganisms particularly 'those of the Gram negative class, and various fungi. The following table illustrates the activity of our new antibiotic against a representative group of microorganisms. The tests were conducted by streaking standard cultures of the icroorganisms on agar which contain various concentrations of the crystalline antibiotic. The values given in the table are those concentrations of acetopyrrothine in meg/ml. of agar, which will just suffice to inhibit completely the growth of the various microorganisms listed.

ent fungi,'many of them pathogenic. This combination of activity against both bacteria and fungi is unusual among antibiotics and is particularly useful in the case of infections from mixtures .of undetermined organisms.

In general, acetopyrrothine is somewhat less active than oxytetracycline, but it is equal to, or more active than, streptomycin against bacteria. The high antifungal activity is evident from the data presented demonstrating that Trichophyton gypseum and Candida albicans strains were completely inhibited by 5 micrograms per ml. or less.

In view of the strong activity against many Gram-negative and Gram-positive bacteria, the activity of acetopyrrothine against certain acidfast bacteria was of interest. Four such strains of Mycobacterium were tested. The results are summarized in the following table.

+=growth of test organism. complete inhibition. :5: doubtful growth.

Whereas the four Mycobacterium strains were not inhibited by 1 microgram of acetopyrrothine per ml., three were completely inhibited by .5 micrograms per ml. In the case of Myco'bacterium 607 questionable results were obtained at the 5 ,microgram level, but complete inhibition was obtained when 10 micrograms were used.

.As a further demonstration of the .antifungal power of acetopyrrothine, several additional strains of pathogenic fungi were tested by the agar streak method. The minimum amountof .acetopyrrothine effecting .complete inhibition was not determined, but the data in the following indicate a high degree of activity. All strains of human pathogens tested were completely inhibited by 5 micrograms per ml., but not by 1 microgram per ml.

Acetopyrrothine in meg/m1.

Histoplasma capsulatum Blastomyces brasz'liensis lsgiorotrichum schenkii.

hialophora verracosav Trichophyton violacium Trz'chophyton sulfureum Microsporum cam's Cryptococcus neoformans llllllll Illlllll Acetopyrrothine in meg/ml.

Alternarz'a salami #1.... Alterncria splani #2 Endothz'a parasitica Neocosmospora vasinfecta Fusarium ozysporium. Nematospora corylii. Phytomonas tumefacz Erwimc amylorora.....

H-+lH-l-lllll llllllllll I+H-l ++l++l l 1 I Crystalline acetopyrrothine has been compared. with other antibiotics using standard test methods. It has been found that when the antibacterial activity of acetopyrrothine is measured by a culture of K. pneumoniae it is found that 1 mg. is as effective as 260-280 mg. of chloramphenicol. When a standard culture of Escherichid 0012 was used as the test organism, it was found that crystalline acetopyrrothine has the equivalent of 560 E. coli dilution units per mg. Using the same type of test, but substituting the organism Trichophyton gypseum, it was found that our new antibiotic has 560 Trichophyton dilution units per milligram activity. In routine testing we employ a standard strain of Bacillus subtilis in a cylinder plate assay similar to that used in the Oxford assay for penicillin. The crystalline antibiotic is assigned a potency of 1000 units per mg. as a standard.

Our invention includes processes for growing our new strain of S. albus. The microorganism may be cultivated at temperatures ranging from about 23 C. to about 32 0. However, we prefer to use temperatures of from 26 C. to 30 C. The organism is best grown under submerged condition of agitation and aeration on media containing carbohydrate source, such as sugars, starch and glycerol; an organic nitrogen source, such as soybean meal, cotton seed meal, peanut meal, and corn steep liquor; and mineral salts, such as sodium chloride, sodium nitrate, magnesium sulfate, and potassium phosphate, In addition to these, a buffering agent, such as calcium carbonate or potassium dihydrogen phosphate, and a foam preventer, such as vegetable oils or animal oils, may be used. We prefer to maintain the pH in the range of from about 6 to about '7. If the medium is adjusted to this point before fermentation, there is little change during the course of production of the antibiotic. During fermentationthe broths are agitated with stirrers of suitable design for incorporating air therein, and they are aerated at the rate of about one-half to two volumes of air per volume of broth per minute. In general, about two days to a week are required for the fermentation broths to reach the maximum antibiotic potency.

Inoculum may be obtained by employing a growth from slants or Roux bottles inoculated with our strain of S. al'ous. Suitable solid media for this initialgrowth are beef-lactose or Emersons agar. This growth is used to inoculate either flasks or inoculum tanks. The time required to reach maximum growth will vary somewhat within the period given above. When inoculum tanks are used, the final broth containing a large amount of fungus is used to inoculate the fermenters.

After the fermentation broth has reached a suitable antibiotic potency, the mycelium is filtered. This may be done without adjustment of the pH, but it has been found that a somewhat higher yield of the antibiotic may be obtained by acidifying the whole broth, heating it and then filtering. We prefer to use a pH of about 2 for this operation and to heat the whole broth for from ten minutes to an hour at about 70-90" C. A filter-aid such as Super-eel is preferably added to the mixture. The pH is raised slightly and the mycelium is removed by means of a filter press or other suitable equipment. The filtered broth so obtained may be used as such, or it may be spray dried to give a product which may be used for local application, but we prefer to purify the material to some extent before using it therapeutically.

Not only is our new antibiotic highly active against a variety of microorganisms but, in addition, it possesses a considerable degree of stability. This, of course, enhances its value as a therapeutic agent in the treatment of various diseases, since it may be prepared in dry form and stored for considerable periods without appreciable loss. The utility of Thiolutin in human and veterinary therapy has not as yet been dem onstrated. We have determined the stability of the antibiotic in the broth that results from the growth of S. albus in a standard culture medium. This determination has been made at acid, neutral and basic pHs, and at both room temperature and C. The following table gives the results of this determination expressed as percentage of activity retained:

Room Temperature (60 minutes) 100 C. (15 minutes) CYIQQ 000::

It will be noticed that the new antibiotic has higher stability in the lower pH range.

Acetopyrrothine may be recovered by various methods from the dilute aqueous solutions produced by fermentation, the most convenient being that of solvent extraction. We have found that practically all of "the antibiotic may he removed from the filtered-fermentation broth'by extraction with water-immiscible, organic solvents, .particularly alcohols, esters, ket'ones, hydrocarbons, ethers and chlorinated organic sol- =vents, at either acid, neutral or basic pI-Ls. "Solvents which we have found particularly useful are butanol, ethyl acetate, methyl 'isobutyl ketone, benzene and chloroform. Extraction may be carried out at any reasonable pI-I, but "we prefer neutral'or somewhat acid'conditions. -By concentration of such organic solvent extracts we may obtain dry preparations of our antibiotic. Materials of this type may be used as *such or the antibiotic may be crystallized from several different'solvents, includingthe lower alcohols, the lower ketones and dimethylformamide or from mixtures of these-solvents with water. We prefer to use methanol for this purpose. The amorphous product is dissolved in the hot solvent, filtered to remove insoluble impurities, and allowed to cool-slowly. The pure antibiotic separates in the form of brilliant yellow, needle shaped crystals. The crystalline solid may then be 'separated from the mother liquor by filtration. Further material may be recovered 'by concentrating the mother liquors, or by adding water. The antibiotic may also be recovered by adsorption of the active material on adsorbents such as activated carbon, followed by elution with a solvent. The compound may also be purified by sublimation at an elevated temperature under vacuum.

Pure crystalline aeeto'pyrrothine is slightly soluble in water. At room temperature-saturated water contains about 1-20micro'gra ms of a'cetopyrrothine per'milliliter. It ismore soluble-in organic solvents, such as butanoL methanol, ethanol, acetone, methylisobutyl ketone, glacial 'acetic'a'cid, dimethylforrnamide, and chloroform. However, its solubility in ethyl ether, petroleum ether, benzene and hexane is more limited. Acetopyrrothine -is "a neutral compound. Averaged analyses of's'amples'of the crystalline compound indicate thef'ollowing composition for acetopyrrothine: 42.09% carbon, 3.53% hydrogen, 12.28% nitrogen, 28.07% sulphur and (by difference) 14.03% 'o'x'yg'en. Based on these analyses wehaveassig'ned the-formula-'CQHsNzOzSz to this antibiotic and determined that it is probably 3-acetamido-5-m'eth'yl -'pyrrolin-'4-ono- (4:;3-d) 1,2-dithiole. The high sulfur content of this acetopyrrothine is a noteworthy characteristic and exceeds thatoi peniciliin, gliotoxin, and sulfactin, other s'u-lfur-containing antibiotics.

The new product is believed to-have the structural formula The method used for naming this fused ring system follows that recommended in Chemical Abstracts, Vol.39, pp. 5867-5975 (1945).

The ultraviolet absorption spectrum of the pure antibiotic in 0.1MKH2PO4 solution (pH 4.5) containing 2% methanol displays at least two distinct maxima. They occur at the following wave lengths: 384 m 314 m i. The ultraviolet absorption spectrum also displays a shoulder at 24521111..

The infrared absorption spectrum of the crys- 8 tall'ine antibiotic was determined with mulls "of the compound in mineral oil and in Fluorolube-S (a commercially available highly fluorinated hydrocarbon). It displays a number of characteristic absorption bands. Among these are the following, the frequencies of which are expressed in reciprocal centimeters (cm.- 3295, 3220,

1091, 1060, 1039, 9'75, 875, 0, 740, 729. The accompanyingdra'wing is'illustrative'of the infrared spectrum.

Crystalline acetopyrrothine has no definite melting point up to 270 C., but thereis evidence of decomposition at temperatures somewhat lower than this point. The crystals darken at about 255 C. An 0.25% solution of the pure antibiotic in glacial acetic acid displays no apparent optical rotation.

It is to be understood that all of the physical constants and analyses reported above are subject to a certain amount of error. Other investigators may find values differing slightly from these.

The following specific examples serve to illustrate how one may carry out our invention, but it is, of course, not limited to the details given therein.

Example I A fermentation medium of the following composition was prepared:

The above 'inaterialswere made up to one liter with tap water and the pH was adjusted to 7 with a sodium hydroxide solution.

500 cc. quantities of the above medium were disposed into Fernbach flasks, and, after stoppering with cotton, the media and apparatus were sterilized for 45 minutes at 121 C. Each of the flasks was then inoculated with 5 ml. of a vegetative culture of one of our new strains of'S. a lbus obtained by propagating the mold in 300 ml. Erlenmeyer flasks at 28 C. for 48 hours on a rotary shaker. The 300 ml. Erlenmeyer flasks had in turn been inoculated from agar slants.

After thefermentation had proceeded for four days, while continuously shaking the Fernbach lasks, the resultant broths were treated with a filter-aid and filtered. The filtered fermentation broths were each found to contain about 75 meg/ml. of acetopyrrothine.

Example II A fermentation broth produced by four days growth of one of our new strains of S. albus on the same medium as in Example '1, at about 28 C.

in shaking flasks, was filtered With the aid of to separate from the methanolic solution. The mixture was stored overnight in a refrigerator, and the crystals were then removed from the supernatant liquor by filtration. The crystalline antibiotic had the equivalent of 280 megs. of chloramphenicol per mg. After two recrystallizations from methanol, the product weighed 230 mgs. representing a recovery of about 16% of the material in the original, clarified fermentation The above amounts of materials were used in a volume made to one liter with tap water.

A suitable volume of the above medium was dispensed into small pots equipped for agitation and aeration. After sterilization, each pot was treated with a small volume of a 48-hour inoculum of an active strain. The pots were stirred at 27 C. to 29 C. and aerated with one volume of air per volume of medium. The potency was determined from time to time, and after four days the product was harvested. The myceliumfree filtrate was found to contain about 90 meg/m1. of acetopyrrothine.

Example IV 150 gallons of a fermentation broth from a three day, aerated, submerged fermentation with one of our new strains of S. albus and using the same medium as in Example III was adjusted to pH 2 with sulfuric acid and was heated to 90 C. for 20 minutes. A filter-aid was added, the pH was adjusted to 3.5, and the mixture was then filtered. The so clarified broth was extracted with onequarter its volume of methyl isobutyl ketone, in a Podbielniak continuous extractor. The organic extract was then concentrated under vacuum to a small volume (2 liters). The amorphous acetopyrrothine which thereupon separated was filtered. This material was crystallized by dissolving it in the minimum volume of hot methanol, filtering and cooling.

It is to be understood that the composition of the culture medium and the conditions of fermentation may be varied within relatively wide limits. Furthermore, many alternative methods for recovering, concentrating and purifying our new antibiotic will be apparent to those skilled in the art. All such obvious modifications in carrying out the present invention are included within the spirit and scope thereof. The patent protection sought is to be limited only as required by the express language of the claims.

We claim:

1. The process for producing acetopyrrothine, which comprises cultivating a pigment-producing strain of Streptomyces albus in NRRL #2401 in an aqueous, nutrient-containing, carbohydrate solution under aerobic conditions, until substantial antibacterial activity is imparted to said solution.

2. A process for producing acetopyrrothine, which comprises cultivating a pigment-producing strain of Streptomyces albus NRRL #2401 under submerged aerobic conditions in an aqueous nutrient medium containing mineral salts, a carbohydrate and an organic nitrogen source, at a temperature ranging from about 23 C. to about 82 0., for a period of from about two days to a week, and then recovering the acetopyrrothine formed from the fermentation broth.

3. A process as claimed in claim 2, wherein the recovery of the acetopyrrothine includes the step of extracting the fermentation broth with an organic water-immiscible solvent.

4. A process as claimed in clam 2, wherein the fermentation broth is acidified, heated and filtered to remove the mycelium, prior to the recovery of the acetopyrrothine from the clarified broth.

5. A new antibiotic identified as acetopyrrothine that is effective against bacteria and fungi, neutral, slightly soluble in water, contains approximately 42.09% carbon, 3.53% hydrogen, 12.28% nitrogen, 28.07% sulphur and (by difference) 14.03% oxygen, and whose mineral oil suspension exhibits a number of characteristic absorption bands in the infrared region of the spectrum among which are the following frequencies expressed in reciprocal centimeters: 3295, 3220, 3110, 1680, 1645, 1607, 1551, 1439, 1322, 1239, 1138, 1091, 1060, 1039, 975, 875, 825, 800, 740, 729.

References Cited in the file of this patent UNITED STATES PATENTS Name Date 'Iishler June 19, 1945 OTHER REFERENCES Number Pratt et al.: Antibiotics (1950), pages 40-41.

Claims (1)

1. 5. A NEW ANTIBIOTIC IDENTIFIED AS ACETOPYRROTHINE THAT IS EFFECTIVE AGAINST BACTERIA AND FUNGI, NEUTRAL, SLIGHTLY SOLUBLE IN WATER, CONTAINS APPROXIMATELY- 42.09% CARBON, 3.53% HYDROGEN, 12.28% NITROGEN, 28.07% SULPHUR AND (BY DIFFERENCE) 14.03% OXYGEN, AND WHOSE MINERAL OIL SUSPENSION EXHIBITS A NUMBER OF CHARACTERISTIC ABSORPTION BANDS IN THE INFRARED REGION OF THE SPECTRUM AMONG WHICH ARE THE FOLLOWING FREQUENCIES EXPRESSED IN RECIPROCAL CENTIMETERS: 3295, 3220, 3110, 1680, 1645, 1607, 1551, 1439, 1322, 1239, 1138, 1091, 1060, 1039, 975, 875, 825, 800, 740, 729.

Images